- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 1JT: 1-(4-methoxy-3-methylbenzyl)-5,6,7,8-tetrahydro-1H-naphtho[2,3-d]imidazole(Non-covalent)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.2: 27 residues within 4Å:- Chain A: G.33, L.34, L.35, S.39, I.40, V.60, C.82, D.83, V.84, S.110, I.111, A.112, F.113, I.138, L.164, T.165, Y.166, K.183, A.209, G.210, P.211, I.212, T.214, L.215, A.216, F.223
- Ligands: 1JT.1
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:I.40, A:Y.166, A:Y.166, A:A.209
- Hydrogen bonds: A:G.33, A:S.39, A:I.40, A:D.83, A:D.83, A:V.84, A:I.111, A:A.112, A:K.183, A:I.212, A:I.212, A:A.216
- Water bridges: A:A.41, A:V.60, A:I.111, A:L.215
NAD.6: 27 residues within 4Å:- Chain B: G.33, L.34, L.35, S.39, I.40, V.60, C.82, D.83, V.84, S.110, I.111, A.112, F.113, I.138, L.164, T.165, Y.166, K.183, A.209, G.210, P.211, I.212, T.214, L.215, A.216, F.223
- Ligands: 1JT.5
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:I.40, B:Y.166, B:Y.166, B:A.209
- Hydrogen bonds: B:G.33, B:I.40, B:D.83, B:V.84, B:I.111, B:A.112, B:K.183, B:I.212, B:I.212, B:T.214, B:A.216
- Water bridges: B:G.33, B:A.41, B:I.111, B:L.215
NAD.11: 27 residues within 4Å:- Chain C: G.33, L.34, L.35, S.39, I.40, V.60, C.82, D.83, V.84, S.110, I.111, A.112, F.113, I.138, L.164, T.165, Y.166, K.183, A.209, G.210, P.211, I.212, T.214, L.215, A.216, F.223
- Ligands: 1JT.10
21 PLIP interactions:21 interactions with chain C- Hydrophobic interactions: C:I.40, C:Y.166, C:Y.166, C:A.209
- Hydrogen bonds: C:G.33, C:I.40, C:D.83, C:D.83, C:V.84, C:I.111, C:A.112, C:Y.176, C:K.183, C:I.212, C:I.212, C:A.216
- Water bridges: C:G.33, C:A.41, C:V.60, C:I.111, C:L.215
NAD.15: 26 residues within 4Å:- Chain D: G.33, L.34, L.35, S.39, I.40, V.60, C.82, D.83, V.84, S.110, I.111, A.112, I.138, L.164, T.165, Y.166, K.183, A.209, G.210, P.211, I.212, T.214, L.215, A.216, F.223
- Ligands: 1JT.14
20 PLIP interactions:20 interactions with chain D- Hydrophobic interactions: D:I.40, D:Y.166, D:Y.166, D:A.209
- Hydrogen bonds: D:G.33, D:I.40, D:D.83, D:V.84, D:I.111, D:A.112, D:K.183, D:I.212, D:I.212, D:T.214, D:A.216
- Water bridges: D:G.33, D:A.41, D:V.60, D:I.111, D:L.215
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 8 residues within 4Å:- Chain A: Y.229, Y.271, V.274, S.275, M.276
- Chain C: Y.229, S.275, M.276
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain C- Hydrogen bonds: A:Y.229, A:S.275, A:M.276, C:M.276
- Water bridges: C:V.274, C:G.277, C:G.277
GOL.7: 8 residues within 4Å:- Chain B: Y.229, S.275, M.276
- Chain D: Y.229, Y.271, V.274, S.275, M.276
9 PLIP interactions:4 interactions with chain D, 5 interactions with chain B- Hydrogen bonds: D:Y.229, D:Y.229, D:S.275, D:M.276, B:Y.229, B:M.276
- Water bridges: B:V.274, B:G.277, B:G.277
- 4 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 3 residues within 4Å:- Chain A: F.113, P.115, R.116
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.116
- Water bridges: A:D.117
- Salt bridges: A:R.116
ACT.8: 3 residues within 4Å:- Chain B: F.113, P.115, R.116
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.116
- Water bridges: B:D.117
- Salt bridges: B:R.116
ACT.12: 2 residues within 4Å:- Chain C: P.115, R.116
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:R.116
- Water bridges: C:D.117
- Salt bridges: C:R.116
ACT.16: 2 residues within 4Å:- Chain D: P.115, R.116
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:R.116
- Water bridges: D:D.117
- Salt bridges: D:R.116
- 3 x NA: SODIUM ION(Non-functional Binders)
NA.9: 3 residues within 4Å:- Chain B: S.86, D.87, Q.88
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.86, B:D.87, B:Q.88
NA.13: 2 residues within 4Å:- Chain C: H.49, N.75
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:H.49, C:N.75
NA.17: 3 residues within 4Å:- Chain D: S.86, D.87, Q.88
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:S.86, D:D.87, D:Q.88
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mehboob, S. et al., Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI). Bioorg.Med.Chem.Lett. (2015)
- Release Date
- 2014-07-23
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 1JT: 1-(4-methoxy-3-methylbenzyl)-5,6,7,8-tetrahydro-1H-naphtho[2,3-d]imidazole(Non-covalent)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 4 x ACT: ACETATE ION(Non-functional Binders)
- 3 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mehboob, S. et al., Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI). Bioorg.Med.Chem.Lett. (2015)
- Release Date
- 2014-07-23
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H